A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

…, J Buter, R De Bree, G Giaccone, MS Lang… - Clinical Cancer …, 2006 - AACR
Purpose: To assess safety, pharmacokinetics, maximum tolerated dose, and preliminary
efficacy of bivatuzumab mertansine. Bivatuzumab is a humanized monoclonal antibody directed …

Telmisartan and amlodipine single‐pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with …

S Neldam, M Lang, R Jones… - The Journal of …, 2011 - Wiley Online Library
J Clin Hypertens (Greenwich). 2011;13:459–466.©2011 Wiley Periodicals, Inc. An 8‐week,
randomized, double‐blind, controlled study with single‐pill combinations of telmisartan 40 …

Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer

…, OC Boerman, R De Bree, M Lang… - Journal of Nuclear …, 2003 - Soc Nuclear Med
From December 1999 until July 2001, a phase I dose escalation study was performed with
186 Re-labeled bivatuzumab, a humanized monoclonal antibody against CD44v6, on …

A phase II study of temozolomide in hormone-refractory prostate cancer

JP van Brussel, MB Busstra, MS Lang… - Cancer chemotherapy …, 2000 - Springer
Introduction: Hormone-refractory disseminated prostate cancer is a major oncological problem.
Preclinical studies with temozolomide, an oral alkylating agent, in prostate cancer have …

[HTML][HTML] Long-term tolerability and efficacy of single-pill combinations of telmisartan 40–80 mg plus amlodipine 5 or 10 mg in patients whose blood pressure was not …

S Neldam, C Edwards, M Lang, R Jones - Current therapeutic research, 2012 - Elsevier
BACKGROUND: Two 8-week, randomized, double-blind, controlled studies previously
evaluated the efficacy and tolerability of single-pill combinations of telmisartan 40–80 mg/…

New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E

MS Lang, RAJ Oostendorp, PJ Simons, W Boersma… - Cancer research, 1994 - AACR
Both retroviral infections as well as human tumors may cause immunosuppression. One of
the factors involved in immunosuppression in patients with squamous cell carcinoma of the …

[BOOK][B] Immunosuppression in Head and Neck Cancer: The role of p15E-related immunosuppressive factors

MS Lang - 1998 - repub.eur.nl
III order to study the relatiollship betweell SCC-HN associated immullosuppressioll alld
retroviral pi5E we produced three lIew mOlloc/ollal antibodies (MAbs: ER-ISI, ER-IS2 alld ER-IS5…

[PDF][PDF] TERCH

…, OC Boerman, R de Bree, M Lang… - RADIOIMMUNO …, 2010 - research.vu.nl
From December 1999 until July 2001, a phase I dose escalation study was performed with
186Re-labeled bivatuzumab, a humanized monoclonal antibody against CD44v6, in patients …

[HTML][HTML] Margreet Van Den Burg.'Geen tweede boer'. Gender, landbouwmodernisering en onderwijs aan plattelandsvrouwen in Nederland, 1863-1968.

H Lauwers - Revue belge de Philologie et d'Histoire, 2004 - persee.fr
… heeft voor de landbouwsector erg lang geduurd. Pas sinds begin … Margreet van der Burg
met haar dissertatie 'Geen tweede boer' hiertoe een belangrijke impuls gegeven. Margreet van …

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

…, D Vetter, M Nicolle, G Kempf-Durepaire, JM Lang - Vaccine, 2000 - Elsevier
Preventing hepatitis B by vaccination is essential in HIV-infected patients (higher progression
rate of HBV infection to chronicity, lower rate of serum HBe Ag loss). However, it has been …